أرسل هذا في رسالة قصيرة: Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with reviously treated advanced non-small-cell lung cancer

  ______     ___                 ___     __   _   
 /_   _//   / _ \\      ___     / _ \\  | || | || 
 `-| |,-   | / \ ||    /   ||  | / \ || | '--' || 
   | ||    | \_/ ||   | [] ||  | \_/ || | .--. || 
   |_||     \___//     \__ ||   \___//  |_|| |_|| 
   `-`'     `---`       -|_||   `---`   `-`  `-`  
                         `-`